E for Ear- E for Epidemic of Hearing Loss in Indian Children
New Delhi: Loss of hearing may have set in, in millions of Children in India, thanks to incessant online classes during COVID 19 pandemic. ENT experts expressed concern on the…
U.S. FDA declines to approve Gilead’s HIV drug on glass vial concerns
The U.S health regulator has declined to approve Gilead Sciences’ injectable drug for the treatment of HIV-1 infection over concerns related to the vials meant for the drug, the company said on…
DoP Enlists 213 Drugs For Which Public Procurement Agencies Could Not Find Local Manufacturers
New Delhi : The Department of Pharmaceuticals (DoP) has initiated efforts to address the issue faced by the Central government’s procurement agencies including the Ministry of Railways and Employees’ State…
Govt Job : For Pharmacist at SCTIMST – Govt of India | Pay upto Rs 1,12,400 pm
Originally established by the Government of Kerala as an advanced centre for medical specialties, Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST) metamorphosed into an Institution of National…
India And Japan To Strengthen Ties In Pharma And Healthcare
Bengaluru : India and Japan will strengthen ties in pharma and healthcare and will chip in expertise and experience. Seven Japanese companies with deep-tech solutions in the fields of medicine,…
Commerce Ministry Relaxes Most Of Restrictions On Exports
New Delhi : The ministry of commerce and industry has stated that it has relaxed most of the restrictions or prohibitions imposed by the Ministry on the products including drug…
Govt Job: For M.Pharm and M.Sc in research at NIPER
National Institute of Pharmaceutical Education and Research (NIPER) is the first national level institute in pharmaceutical sciences with a proclaimed objective of becoming a centre of excellence for advanced studies…
SII seeks permission for phase-3 study of Covid vaccine Covovax as booster dose in adults
NEW DELHI: Serum Institute of India has sought permission from India’s drug regulator to conduct a phase-3 study of its Covid-19 vaccine Covovax as a booster dose in adults, official sources said…
Aurobindo, Sun Pharma Recall Products In US Market For Defaulting Norms
New Delhi : Leading homegrown drug makers Aurobindo Pharma and Sun Pharmaceutical Industries are recalling different products in the US market due to deviation from standard manufacturing norms. According to the…
Govt Job: For Pharmacist at AIIMS in the department of Community & Family Medicine
The establishment of the All India Institute of Medical Sciences (AIIMS) at New Delhi in 1956 was a dream project of first Prime Minister of India, Shri Jawahar Lal Nehru and this…

Civil society group SAM calls for greater transparency involving clinical trials
Different packaging, typos expose fake Mounjaro racket
To Eat or not to Eat, if this Dilemma is ‘Eating’ you, ‘Eat’ this Book
NCB Hyderabad raids illegal lab, seizes 69 kg of Alprazolam worth Rs 17.4 crore
Rajasthan Bans 7 Sub-Standard Medicines
ONESOURCE’s partner receives USFDA tentative approval for Semaglutide Injection
Ajanta Pharma gets USFDA Form 483 with five observations at Paithan plant
Obesity drug market to gain as Indians pop the pill and Chinese bring more
Aurobindo Pharma Rs 800 Cr Buyback Opens Apr 23
Boehringer Ingelheim launches AI centre for pharma research in London